Figitumumab (Anti-IGF1R / CD221)

Synonyms: CP-751871

Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.

Figitumumab (Anti-IGF1R / CD221)

Purity & Quality Control

≥99

Choose Selective IGF-1R Inhibitors

Biological Activity

Description Figitumumab (Anti-IGF1R / CD221) is a human monoclonal antibody directed against the insulin-like growth factor type I receptor (IGF1R) with potential antineoplastic activity. Figitumumab prevents IGF1 from binding to IGF1R with an IC50 of 1.8 nM. MW: 146.0 KD.

Product Details

CAS No. 943453-46-1
Molecular Weight 146
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Figitumumab (Anti-IGF1R / CD221) | Figitumumab (Anti-IGF1R / CD221) supplier | purchase Figitumumab (Anti-IGF1R / CD221) | Figitumumab (Anti-IGF1R / CD221) cost | Figitumumab (Anti-IGF1R / CD221) manufacturer | order Figitumumab (Anti-IGF1R / CD221) | Figitumumab (Anti-IGF1R / CD221) distributor